Translational Insights Support NurOwn ® as a Best-In-Class Strategy in ALS NEW YORK and PETACH TIKVAH, Israel, Oct. 04, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results